Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: Reliability of relatively high doses administered over a relatively short period

Clinical Infectious Diseases

Volumn 20, Issue 2, 1995, Pages 263-266

  Lalla, Fausto De ^a   Pellizzer, Giampietro ^a   Vaglia, Alberto ^a   Manfrin, Vinicio ^a   Franzetti, Marzia ^a   Fabris, Paolo ^a   Stecca, Clara ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRYPTOCOCCOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; CRYPTOCOCCOSIS; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; HUMAN; ITRACONAZOLE; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGE; REPRODUCIBILITY OF RESULTS;

EID: 0028854460     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.2.263     Document Type: Article

References (19)

1. Dismukes WE. Management of cryptococcosis. Clin Infect Dis 1993; 17(suppl 2):S507-12.
2. Clumeck N, Carael N, Van de Perre P. The African AIDS experience in contrast with the rest of the world. In: Leoung G, Mills J, eds. Opportunistic infections in patients with the acquired immunodeficiency syndrome. New York: Marcel Dekker, 1989:43-56.
3. Chuck SL. Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321:794-9.
4. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated crypto- coccal meningitis. N Engl J Med 1992;326:83-9.
5. Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990; 12:768-77.
6. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococ- cal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 1986;104:234-40.
7. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993;17:837-42.
8. Spitzer ED, Spitzer SG, Freundlich LF, Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993;341:595-6.
9. Larsen RA, Bozzette S, McCutchan JA, et al. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Intern Med 1989; 111:125-8.
10. Powderly WG. Therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1992; 14(suppl l):S54-9.
11. Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103:533-8.
12. Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann Intern Med 1990; 113:183-7.
13. de Gans J, Portegies P, Tiessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-90.
14. Bozzette SA, Larsen RA, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 1991; 324:580-4.
15. Armstrong D. Treatment of opportunistic fungal infections. Clin Infect Dis 1993;16:1-9.
16. Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:1962-72.
17. Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:793-8.
18. Fisher MA, Talbot GH, Maislin G, McKeon BP, Tynan KP, Strom BL. Risk factors for amphotericin B-associated nephrotoxicity. Am J Med 1989;87:547-52.
19. Butler WT, Bennett JE, Ailing DW, Wertlake PT, Utz JP, Hill GJ II. Nephrotoxicity of amphotericin B: early and late effects in 81 patients. Ann Intern Med 1964;61:175-87.